RECORD // Company

Scribe Therapeutics, Inc.

Built 2026-11-22T03:06:29Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (2)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Scribe Therapeutics Inc. · Ctgov · same registered legal name as 'Scribe Therapeutics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • SCRIBE THERAPEUTICS INC · Epa echo · same registered legal name as 'Scribe Therapeutics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

5 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001193125-26-458503

ItemValuePeriodFormFiledAccessionReport
Revenue$1,636,0003 months ended 2026-09-3010-Q2026-11-120001193125-26-4585032026-11-22 03:06 UTCReport an error
Net income (loss)$-9,863,0003 months ended 2026-09-3010-Q2026-11-120001193125-26-4585032026-11-22 03:06 UTCReport an error
Interest expense$875,0009 months ended 2026-09-3010-Q2026-11-120001193125-26-4585032026-11-22 03:06 UTCReport an error
Cash and cash equivalents$172,050,000at 2026-09-3010-Q2026-11-120001193125-26-4585032026-11-22 03:06 UTCReport an error
Contract liabilities (total)$38,372,000at 2026-09-3010-Q2026-11-120001193125-26-4585032026-11-22 03:06 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001853921
Ticker
SCTX
EIN
822157847
UEI
E9LNGD3EP3H8
CUSIP
811033109
Record ID
sx:sec:0001853921

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

16 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-16SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
Business address1150 MARINA VILLAGE PKWY, ALAMEDA, CA, 945012026-11-16SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
ExchangesNasdaq2026-11-16SEC EDGAR company profile2026-11-22 03:06 UTCReport an error
Form D total offering amount (D filed 2021-04-02)$100,000,0022021-04-02D2026-11-22 03:06 UTCReport an error
Form D total amount sold (D filed 2021-04-02)$100,000,0022021-04-02D2026-11-22 03:06 UTCReport an error
Form D industry groupOther Technology2021-04-02D2026-11-22 03:06 UTCReport an error
Form D revenue rangeDecline to Disclose2021-04-02D2026-11-22 03:06 UTCReport an error
Form D date of first sale2021-03-172021-04-02D2026-11-22 03:06 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-12)On November 12, 2026, Scribe Therapeutics Inc. (the "Company") announced its financial results for the quarter ended September 30, 2026 and provided a business update. A copy of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the "Securities…2026-11-12SEC EDGAR 8-K 0001193125-26-458486 (text as filed, excerpt)2026-11-22 03:06 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-09-02)On September 2, 2026, Scribe Therapeutics Inc. (the "Company") announced its financial results for the quarter ended June 30, 2026 and provided a business update. A copy of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the "Securities…2026-09-02SEC EDGAR 8-K 0001193125-26-380184 (text as filed, excerpt)2026-11-22 03:06 UTCReport an error
Plan (pension, plan no. 001)SCRIBE THERAPEUTICS INC.: 139 participants, assets $9,549,9532025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 03:06 UTCReport an error
Federal award transactions, fiscal year 2026 (this one registration only)$02026-09-30USAspending recipient profile2026-11-22 03:06 UTCReport an error
Number of federal award transactions, fiscal year 2026 (this one registration only)02026-09-30USAspending recipient profile2026-11-22 03:06 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.